Perspectives in Affective Disorders: International Symposium '25 Years Weissenau Depression Unit', Weissenau, September 2001Available to Purchase
In this publication a comprehensive overview of the state of the art and future perspectives is given in the fields of basic research, diagnosis, therapy, suicide and relapse prevention, and psychiatric care regarding patients with affective disorders.
Presented are decisive new developments which have been milestones in basic research or diagnosis, pharmacotherapy and psychotherapy of affective disorders. The contributions of renowned experts in the field include quantitative brain morphology and developments in genetics and neurochemistry. Special attention has been given to neuropharmacology, pharmacogenetics, electrophysiology, structural and functional neuroimaging of affective disorders as well as new therapeutic options in the field of psychotherapy. Moreover, important clinical issues such as modern aspects of preventing relapse, suicide and postnatal depression in mothers are discussed.
Psychiatrists, psychotherapists, neurobiologists and students who participate in the treatment of patients with affective diseases will find this book valuable reading.
Download citation file:
Digital Version
Print Version
Table of Contents
-
1 - 7: Historical Comments on the Foundation of the Weissenau Depression UnitByG. HoleG. HoleWeissenau State Psychiatric Hospital and First Department of Psychiatry, University of Ulm, Ravensburg, GermanySearch for other works by this author on:
-
8 - 24: Inpatient Treatment of Depression: The Significance of Special Units for Patients with Depressive Diseases: Survey, Conception and Current State of ExperienceByM. WolfersdorfM. WolfersdorfDepartment of Psychiatry and Psychotherapy, Bayreuth Depression Centre, Bayreuth District Hospital, Bayreuth, Germany, and ‘Working Party of German and Swiss Depression Units’Search for other works by this author on:
-
25 - 34: Screening and Utilization of Treatment in Mothers with Postnatal DepressionByC.-L. von Ballestrem;C.-L. von BallestremaCenter for Psychotherapy Research, Stuttgart,Search for other works by this author on:M. Strauss;M. StraussaCenter for Psychotherapy Research, Stuttgart,Search for other works by this author on:H. KächeleH. KächeleaCenter for Psychotherapy Research, Stuttgart,bDepartment of Psychotherapy and Psychosomatic Medicine, University of Ulm, GermanySearch for other works by this author on:
-
35 - 62: Genetics of Mood Disorders: Current Status of Knowledge and ProspectsByW. MaierW. MaierDepartment of Psychiatry, University of Bonn, GermanySearch for other works by this author on:
-
63 - 69: Functional Neuroimaging of DepressionByS. Erk;S. ErkPsychiatrische Klinik, Abteilung Psychiatrie III, Universitätsklinikum Ulm, DeutschlandSearch for other works by this author on:H. Walter;H. WalterPsychiatrische Klinik, Abteilung Psychiatrie III, Universitätsklinikum Ulm, DeutschlandSearch for other works by this author on:M. SpitzerM. SpitzerPsychiatrische Klinik, Abteilung Psychiatrie III, Universitätsklinikum Ulm, DeutschlandSearch for other works by this author on:
-
70 - 78: Affective Disorders and Alterations of Cardiac Autonomic Nervous System ControlByT. RechlinT. RechlinAbteilung für Psychiatrie, Psychotherapie und Psychosomatik, Kreiskrankenhaus Rendsburg, DeutschlandSearch for other works by this author on:
-
79 - 94: New Antidepressants in Comparison with Classical Tricyclics: Mechanisms of Action and Clinical EvaluationByA. Broocks;A. BroocksaDepartment of Psychiatry and Psychotherapy, University Medical School, Lübeck;Search for other works by this author on:K. Junghanns;K. JunghannsaDepartment of Psychiatry and Psychotherapy, University Medical School, Lübeck;Search for other works by this author on:A. Thiel;A. ThielbDepartment of Psychiatry and Psychotherapy, Diakonie Hospital, Rotenburg/Wümme;Search for other works by this author on:C.H. Gleiter;C.H. GleitercDepartment of Clinical Pharmacology, University of Tübingen, andSearch for other works by this author on:B. BandelowB. BandelowdDepartment of Psychiatry and Outpatient Clinic, University of Göttingen, GermanySearch for other works by this author on:
-
95 - 111: Therapy with Antidepressants: Pharmacogenetic AspectsByP. Baumann;P. BaumannaUnité de Biochimie et Psychopharmacologie Clinique, Département Universitaire de Psychiatrie Adulte, Prilly-Lausanne, andSearch for other works by this author on:D.F. Zullino;D.F. ZullinoaUnité de Biochimie et Psychopharmacologie Clinique, Département Universitaire de Psychiatrie Adulte, Prilly-Lausanne, andSearch for other works by this author on:E. Jaquenoud Sirot;E. Jaquenoud SirotbForschungsleitung, Psychiatrische Dienste des Kantons Aargau, Brugg, SwitzerlandSearch for other works by this author on:E. Paus;E. PausaUnité de Biochimie et Psychopharmacologie Clinique, Département Universitaire de Psychiatrie Adulte, Prilly-Lausanne, andSearch for other works by this author on:C.B. EapC.B. EapaUnité de Biochimie et Psychopharmacologie Clinique, Département Universitaire de Psychiatrie Adulte, Prilly-Lausanne, andSearch for other works by this author on:
-
112 - 136: Molecular Mechanisms of Action of Mood Stabilizers in Bipolar DisorderByD. van CalkerD. van CalkerDepartment of Psychiatry and Psychotherapy, University of Freiburg, GermanySearch for other works by this author on:
-
137 - 145: Antisuicidal Effect of Lithium as a Criterion for the Selection of Appropriate Long-Term Medication in Bipolar PatientsByA. Berghöfer;A. BerghöferaInstitute of Social Medicine, Epidemiology and Health Economics, andSearch for other works by this author on:M. Bauer;M. BauerbDepartment of Psychiatry, Charité Hospital, Humboldt University, Berlin, Germany;cNeuropsychiatric Institute and Hospital, Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles (UCLA), Los Angeles, Calif., USA, andSearch for other works by this author on:B. Müller-OerlinghausenB. Müller-OerlinghausendDrug Commission of the German Medical Association, Berlin and Cologne, GermanySearch for other works by this author on:
-
146 - 166: Mechanisms and Management of Weight Gain Associated with Drug Treatment of Affective DisordersByU. Zimmermann;U. ZimmermannMax-Planck-Institute of Psychiatry, Munich, GermanySearch for other works by this author on:T. Kraus;T. KrausMax-Planck-Institute of Psychiatry, Munich, GermanySearch for other works by this author on:T. PollmächerT. PollmächerMax-Planck-Institute of Psychiatry, Munich, GermanySearch for other works by this author on:
-
167 - 177: Electromagnetic Stimulation and Affective DisordersByK.P. Ebmeier;K.P. EbmeierDepartment of Psychiatry, University of Edinburgh, UKSearch for other works by this author on:J.M. LappinJ.M. LappinDepartment of Psychiatry, University of Edinburgh, UKSearch for other works by this author on:
-
178 - 187: Cyclothymic But Not Depressive Temperament Influences the Mood of Another Person in Social InteractionsByM. Hautzinger;M. HautzingerUniversity of Tübingen, GermanySearch for other works by this author on:B.L. PheasantB.L. PheasantUniversity of Tübingen, GermanySearch for other works by this author on:
-
188 - 196: Pathological Crying: Modern Treatment OptionsByW.P. Kaschka;W.P. KaschkaaDepartments of Psychiatry I andSearch for other works by this author on:A. Meyer;A. MeyerbNeurology and Epileptology, University of Ulm, Weissenau Psychiatric Hospital, Ravensburg, GermanySearch for other works by this author on:W. FröscherW. FröscherbNeurology and Epileptology, University of Ulm, Weissenau Psychiatric Hospital, Ravensburg, GermanySearch for other works by this author on: